Outsourcing Provides Advantages to Sponsor Companies
Arto Toivonen
Fermion
PAP-Q4-15-CL-001Oct 01, 2015
Bolstering Capabilities for Parenteral Drug Development and Manufacturing
Syed T. Husain
Alcami
PAP-Q4-15-CL-005Oct 01, 2015
Digital Automation in Clinical Trials: The Promise and Potential
Zaher El-Assi
Merge eClinical
PAP-Q4-15-CL-006Oct 01, 2015
Special Focus-Achieving Strong Customer Perception: The Customer Experience
Guy Tiene
Nice Insight
PAP-Q4-15-VP-001Oct 01, 2015
Be Innovative! Maneuvering the Global Pharmaceutical Market
Nigel Walker
Nice Insight
PAP-Q4-15-NO-001Oct 01, 2015
Risk Minimization through Careful CDMO Selection
Greg Flyte
GSK Contract Manufacturing
PAP-Q4-15-CL-003Oct 01, 2015
In-depth Process and Product Expertise – This is Key to CDMO Support of Orphan Drug and Breakthrough Therapy Development & Commercialization
Kristine K. Senft
Nice Insight
PAP-Q4-15-CL-004Oct 01, 2015
What Does It Mean to be a Full-Service CDMO?
Stephen A. Munk, Ph.D
Ash Stevens
PAP-Q4-15-CL-002Oct 01, 2015
Innovative Strategies to Meet Today’s Changing Equipment Needs
Larry Kadis
Federal Equipment Company
PAP-Q4-15-CL-009Oct 01, 2015
Choosing the Optimal Drug Delivery System to Meet Patient Needs
Kevin Haehl
Unither Pharmaceuticals
PAP-Q4-15-CL-008Oct 01, 2015
Ensuring the Integrity of Temperature-Sensitive Drugs Along the Cold Chain: What You Can Do To Mitigate Risk
Jay McHarg
AeroSafe Global
PAP-Q4-15-CL-007Oct 01, 2015
Cultural Competence In Pharma: Multicultural Marketing Is No Longer Innovation, It’s Competitive Advantage
Rhea Kim, Ph.D.
Nice Consulting
PAP-Q4-15-NC-001Oct 01, 2015